HOXB5 protein upregulates the expression of mesenchymal markers such as VIM, SNAI1, and SNAI2 and downregulates the expression of CDH1, to enhance the mesenchymal transition, motility, and migratory ability of cancer cells (Gao et al. 2020). Here, HOXB5 is linked to cancer.